Your session is about to expire
← Back to Search
Metoprolol for Coronary Artery Disease (POINT-NOCAD Trial)
POINT-NOCAD Trial Summary
This trial is testing if a anti-inflammatory drug can help patients with ischemic heart disease who have non-obstructive coronary artery disease.
POINT-NOCAD Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPOINT-NOCAD Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.POINT-NOCAD Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have stable heart disease or had a recent heart attack.My kidney function is normal or only mildly reduced.I am 18 or older and have been referred for a heart artery check.You are allergic to the dye used in angiographic or catheterization procedures.You have significant blockages in one or more of the main heart arteries, as shown by a special heart X-ray test.
- Group 1: Intervention group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Can potential participants still join this clinical experiment?
"Clinicaltrials.gov reports that this medical study is presently searching for participants. It was initially advertised on the 12th of July 2021 and recently revised on the 1st of July 2022."
May I be considered as a candidate for this research study?
"Patients with coronary artery disease that are between 18 and 125 years old can potentially enroll in this trial. A total of 100 participants is the goal for recruitment."
Are there any historical instances of Coronary computed tomography angiography (CCTA) being tested in clinical trials?
"Currently, the search for a Coronary computed tomography angiography (CCTA) solution is in full swing with 28 trials under way and 4 of them at Phase 3. The majority are being conducted out of Orlando, Florida but there exists an aggregate total of 164 locations running these clinical investigations."
How is Coronary computed tomography angiography (CCTA) typically employed to assist patients?
"Coronary computed tomography angiography (CCTA) is typically used to address episodes of chest pain, but can also be deployed in the treatment of myocardial infarction and adrenergic alpha-antagonist related issues. Additionally, CCTA is commonly prescribed for use as a diagnostic tool during a procedure known as myelography."
How extensive is the participant base of this experiment?
"Yes, according to the current information on clinicaltrials.gov, this clinical trial is actively seeking participants and is accepting a total of 100 patients from 1 site between July 2021 and July 2022."
Are participants over the age of 70 precluded from participating in this trial?
"The parameters for participation in this trial necessitate that applicants must be aged between 18 and 125. There are 53 studies open to minors, with 916 trials available for those above the age of retirement."
Share this study with friends
Copy Link
Messenger